About Cirex Pharmaceuticals Private Limited
Data last updated:
Cirex Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 December 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1990PTC012119. Its GSTIN is 36AAACC9554A1ZW (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.15 Cr. It was formerly known as Cirex Pharmaceuticals Limited and Scirex Pharmaceuticals Limited. It is led by directors Navin Kumar Reddy Puchakayala and Chandra Sekhar Tumuluru.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 8 – 3 – 166/7/1 Erragadda, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.51 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.37 Cr (net margin 12.3%) and EBITDA of ₹6.41 Cr (EBITDA margin 23.3%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 18% over five years.
As per MCA filings, the company has satisfied charges of ₹109.73 Cr on record. Court records list 31 cases involving the company, including 15 filed by the company and 16 filed against it; 12 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cirexpharma.com.
Company details
Name history
Cirex Pharmaceuticals has undergone 3 name changes throughout its history. The company was previously known as Cirex Pharmaceuticals Limited, Scirex Pharmaceuticals Limited, and Cirex Pharmaceuticals Private Limited. The current legal name is Cirex Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Cirex Pharmaceuticals Private Limited | Current |
| Cirex Pharmaceuticals Limited | Previous |
| Scirex Pharmaceuticals Limited | Previous |
CIN history
Cirex Pharmaceuticals has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TG1990PTC012119, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1990PTC012119 | Current |
| U24239TG1990PLC012119 | Previous |
| L24239AP1990PLC012119 | Previous |
| U24239AP1990PLC012119 | Previous |
Contact details
Cirex Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is cirexpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No. 8 – 3 – 166/7/1 Erragadda, Hyderabad, Telangana, India – 500018
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cirex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cirex Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cirex Pharmaceuticals Private Limited, buy the company report.
Financials of Cirex Pharmaceuticals Private Limited
FY 2025 filings availableCirex Pharmaceuticals Private Limited reported revenue of ₹27.51 Cr (up 487% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 487% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 18%. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.37 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.3% | ||||
| Net Profit Margin | 12.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cirex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cirex Pharmaceuticals Private Limited
Cirex Pharmaceuticals has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Navin Kumar Reddy Puchakayala Also directs: Anagen Labs Private Limited | Director | 17 Jun 2021 | 5 Years 4 Months | Current |
| Chandra Sekhar Tumuluru | Director | 14 Jul 2015 | 11 Years 3 Months | Current |
Peer comparison
Cirex Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jips Pharmaceuticals Private Limited | ₹27.63 Cr (FY 2023) | 19.0% | Chandigarh, India | |||
| Quixotic Pharma Private Limited | ₹27.58 Cr (FY 2025) | -8.0% | Punjab, India | |||
| Augxen Pharma Private Limited | ₹27.52 Cr (FY 2025) | 134.0% | Bharuch, Gujarat, India | |||
| Cirex Pharmaceuticals Private Limitedthis company | ₹27.51 Cr (FY 2025) | ₹3.37 Cr | 12.3% | 487.0% | Hyderabad, Telangana, India | |
| Acme Diet Care Private Limited | ₹27.35 Cr (FY 2025) | 17.0% | Ahmedabad, Gujarat, India | |||
| Riconpharma India Private Limited | ₹27.3 Cr (FY 2024) | 24.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Cirex Pharmaceuticals Private Limited, buy the company report.
Auditor
Cirex Pharmaceuticals Private Limited is audited by M V Narayana Reddy & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M V Narayana Reddy & Co | FY 2023 | 002370S |
Shareholding
The shareholding of Cirex Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cirex Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 May 2009 | 10163194 | State Bank of Hyderabad | ₹74 Cr | Satisfied | |
| 09 Feb 2001 | 90124225 | State Bank of Hyderabad | ₹34.5 Cr | Satisfied | |
| 29 Mar 1995 | 90120833 | Indian Overseas Bank | ₹5 Lakh | Satisfied | |
| 20 Mar 1995 | 90120822 | Ap State Financial Corporation | ₹55.8 Lakh | Satisfied | |
| 22 Mar 1991 | 80066708 | Andhra Pradesh State Financial Corporation | ₹62.2 Lakh | Satisfied |
To see the full charge records of Cirex Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Cirex Pharmaceuticals Private Limited has 31 court cases on record: 15 filed by Cirex Pharmaceuticals, 16 filed against it. 12 cases are pending and 19 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 29 | 14 | 12 |
| District courts | 1 | 1 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 31)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Arbitration matter | Filed by the company against The New India Assurance Company Limited | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against Transmission Corporation of Telangana Ltd and 6 others | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against Southern Power Distribution Company of Telangana Ltd., and 2 others | Pending |
| High Court | Court case (CARAP) | Filed by the company against The New India Assurance Company Limited | Disposed |
| High Court, TAMIL NADU | Appeal | Filed against the company by United India Insurance Co.Ltd | Disposed |
To see the full case history of Cirex Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cirex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cirex Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 27, 2024.
GST
Cirex Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACC9554A1ZW | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cirex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cirex Pharmaceuticals Private Limited has 12 board changes on record since 2009: 2 appointments and 10 cessations. The latest: Navin Kumar Reddy Puchakayala ceased to be Additional Director on 29 Nov 2021.
17 earlier events are in the company report.
Frequently asked questions
Cirex Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 December 1990 (36+ years old) and is registered under CIN U24239TG1990PTC012119.
Cirex Pharmaceuticals has 2 current directors:
- Navin Kumar Reddy Puchakayala - Director
- Chandra Sekhar Tumuluru - Director
The latest financial statements of Cirex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cirex Pharmaceuticals is 36AAACC9554A1ZW, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Cirex Pharmaceuticals is U24239TG1990PTC012119. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cirex Pharmaceuticals has 31 court cases on record: 15 filed by the company and 16 filed against it. 12 are pending. Most are in the high courts.
Cirex Pharmaceuticals was incorporated on 21 December 1990, making it 36+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Cirex Pharmaceuticals by revenue are Jips Pharmaceuticals Private Limited, Quixotic Pharma Private Limited, Augxen Pharma Private Limited, Acme Diet Care Private Limited, Riconpharma India Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Navin Kumar Reddy Puchakayala ceased to be Additional Director on 29 Nov 2021. Navin Kumar Reddy Puchakayala was appointed as Director on 17 Jun 2021. Rathnakar Reddy Kura ceased to be Director on 17 Jun 2021. Cirex Pharmaceuticals has 12 board changes on record in total.
Cirex Pharmaceuticals can be reached through the website cirexpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Cirex Pharmaceuticals is at H.No. 8 – 3 – 16671 Erragadda, Hyderabad, Telangana, India – 500018.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
